About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Francisco | 209 Studies

Clinical Trials Prostate CancerSan Francisco

Prostate Cancer Clinical Trials in San Francisco

Find 209 clinical trials for prostate cancer near San Francisco, California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Francisco

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 209 trials

RecruitingComparison of 177Lu-PSMA-617 and 225Ac-PSMA-617There is evidence that Actinium-225 Prostate-Specific Membrane Antigen (225Ac-PSMA) has a potentially higher level of efficacy than 177 Lutetium Prostate-Specific Membrane Antigen…NCT07054346·San Francisco, California CompletedKetoconazole and Dexamethasone in Prostate CancerThis is an open label, phase II, single center trial of ketoconazole/dexamethasone to determine if the administration of ketoconazole/dexamethasone, after disease progression with…NCT01036594·San Francisco, California RecruitingSocial, Structural, and Lifestyle Drivers of Prostate Cancer DisparitiesProstate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States.NCT07690579·San Francisco, California

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsThe goal of this clinical trial is to determine the most effective dose of EIK1005 that a person can take safely.NCT07262619·Los Angeles, California and 44 others

Terminated68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate CancerThis phase II trial studies the use of 68Ga-PSMA-11 positron emission tomography (PET) in diagnosing patients with prostate cancer that continues to grow despite the surgical…NCT04716725·San Francisco, California

Active not recruitingPredicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate CancerRATIONALE: Gathering information about the Gleason score, prostate-specific antigen (PSA) level, and cancer stage from patients who have undergone radiation therapy for prostate…NCT00769223·San Francisco, California

UnknownA Study Evaluating MM-310 in Patients With Solid TumorsMM-310 is a liposomal formulation of a docetaxel prodrug that targets the EphA2 receptor on cancer cells.NCT03076372·Scottsdale, Arizona and 4 others

RecruitingAbemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate CancerThis phase I/II trial tests the safety, side effects, and best dose of abemaciclib and whether it works before 177Lu-PSMA-617 in treating patients with castration resistant…NCT05113537·San Francisco, California

RecruitingEvaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerThe primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an oral Gonadotropin-releasing…NCT06613100·San Francisco, California and 8 others

CompletedWeb-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8A randomized controlled trial of a technology-based lifestyle intervention vs. usual care among men with low-risk prostate cancer to determine the feasibility and acceptability of…NCT02470936·San Francisco, California

CompletedDocetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Androgens can stimulate the growth of prostate cancer cells. Estramustine may fight prostate cancer by reducing the production of androgens.NCT00052845·Anniston, Alabama and 79 others

RecruitingA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in…NCT06136650·Tucson, Arizona and 329 others

RecruitingHyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceThis phase II trial studies the side how well hyperpolarized carbon C 13 pyruvate (HP C-13 pyruvate) magnetic resonance imaging (MRI) works in monitoring patients with prostate…NCT03933670·San Francisco, California

RecruitingStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerThis phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants…NCT03678025·Gilbert, Arizona and 337 others

CompletedAndrogen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideThis is a prospective, randomized, open-label phase II study comparing cognitive outcomes between men with metastatic and non-metastatic castration resistant prostate cancer…NCT04335682·San Francisco, California and 7 others

RecruitingStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant…NCT06136624·Orange, California and 287 others

RecruitingA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel…NCT07213674·Goodyear, Arizona and 158 others

CompletedProstate Cancer Intervention Versus Observation Trial (PIVOT)Radical prostatectomy provides potentially curative removal of the cancer.NCT00007644·Birmingham, Alabama and 30 others

CompletedA Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how participants with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency…NCT02975934·Birmingham, Alabama and 149 others

CompletedLEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCThis is a Phase Ib/II open label clinical trial in patients with metastatic castration resistant prostate cancer.NCT02494921·San Francisco, California and 5 others

PreviousPage 9 of 11Next

Other Conditions in San Francisco

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma